Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001474506-24-000252
Filing Date
2024-11-18
Accepted
2024-11-18 21:00:34
Documents
1
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3518
  Complete submission text file 0001474506-24-000252.txt   5279
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Issuer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 139, TECHNO JUNGANG-DAERO YUGA-MYEON, DALSEONG-GUN DAEGU M5 43020
Business Address 139, TECHNO JUNGANG-DAERO YUGA-MYEON, DALSEONG-GUN DAEGU M5 43020 82-53-582-8036
Abpro Bio International, Inc. (Reporting) CIK: 0002044844 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41224 | Film No.: 241473131